Aytu BioScience Inc Forecast, price target & analysts
Aytu BioScience Inc Target price 2025 - Analyst rating & recommendation
Aytu BioScience Inc Classifications & Recommendation:
Aytu BioScience Inc Price Target
| Target Price | $8.16 |
| Price | $2.13 |
| Potential |
283.10%
register free of charge
|
| Number of Estimates | 5 |
|
5 Analysts have issued a price target Aytu BioScience Inc 2026 .
The average Aytu BioScience Inc target price is $8.16.
This is
283.10%
register free of charge
$13.13
516.20%
register free of charge
$7.07
231.92%
register free of charge
|
|
| A rating was issued by 9 analysts: 8 Analysts recommend Aytu BioScience Inc to buy, 1 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Aytu BioScience Inc stock has an average upside potential 2026 of
283.10%
register free of charge
|
Sales and Margin forecast 2026, 2027 & 2028
| Jun '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Million $ | 66.38 | 56.98 |
| 1.84% | 14.16% | |
| EBITDA Margin | 9.37% | 1.96% |
| 43.71% | 79.08% | |
| Net Margin | -20.43% | -29.80% |
| 15.94% | 45.88% |
5 Analysts have issued a sales forecast Aytu BioScience Inc 2026 . The average Aytu BioScience Inc sales estimate is
This results in the following potential growth metrics:
5 Analysts have issued an Aytu BioScience Inc EBITDA forecast 2026. The average Aytu BioScience Inc EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
5 Aytu BioScience Inc Analysts have issued a net profit forecast 2026. The average Aytu BioScience Inc net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 & 2028
| Jun '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -2.15 | -1.71 |
| 24.83% | 20.47% | |
| P/E | negative | |
| EV/Sales | 0.27 |
5 Analysts have issued a Aytu BioScience Inc forecast for earnings per share. The average Aytu BioScience Inc EPS is
This results in the following potential growth metrics and future valuations:
Aytu BioScience Inc...
Current Aytu BioScience Inc Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Ascendiant Capital |
Locked
➜
Locked
|
Locked | Sep 25 2025 |
| Maxim Group |
Locked
➜
Locked
|
Locked | Sep 25 2025 |
| Lake Street |
Locked
➜
Locked
|
Locked | Jul 01 2025 |
| Ascendiant Capital |
Locked
➜
Locked
|
Locked | Jun 30 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
Ascendiant Capital:
Locked
➜
Locked
|
Sep 25 2025 |
|
Locked
Maxim Group:
Locked
➜
Locked
|
Sep 25 2025 |
|
Locked
Lake Street:
Locked
➜
Locked
|
Jul 01 2025 |
|
Locked
Ascendiant Capital:
Locked
➜
Locked
|
Jun 30 2025 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
